Abbott Laboratories (ETR:ABL)
Germany
· Delayed Price · Currency is EUR | Market Cap | 223.90B |
| Revenue (ttm) | 40.52B |
| Net Income (ttm) | 12.94B |
| Shares Out | n/a |
| EPS (ttm) | 7.38 |
| PE Ratio | 17.30 |
| Forward PE | n/a |
| Dividend | 2.10 (1.62%) |
| Ex-Dividend Date | Jan 15, 2025 |
| Volume | 732 |
| Average Volume | 903 |
| Open | 127.00 |
| Previous Close | 126.62 |
| Day's Range | 126.30 - 129.32 |
| 52-Week Range | 90.00 - 129.32 |
| Beta | 0.74 |
| RSI | 71.78 |
| Earnings Date | Apr 16, 2025 |
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,... [Read more]
Financial Performance
In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.40 billion, an increase of 135.08%.
Financial numbers in USD Financial StatementsNews
Abbott Declares 405th Consecutive Quarterly Dividend
ABBOTT PARK, Ill., Feb. 21, 2025 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
On Thursday, Dexcom, Inc.'s (NASDAQ: DXCM) fourth-quarter revenue rose 8% year-over-year to $1.114 billion, beating the analyst consensus estimate of $1.104 billion . U.S. revenue rose by 4%, while i...
Rep. Emily Randall Has Sold Up to $165K Worth Of Abbott Laboratories Stock: Here's What You Should Know
February 11, 2025 records indicate that Representative Emily Randall filed a sale of Abbott Laboratories (NYSE: ABT), valued between $11,011 and $165,000. According to the February filing, the transa...
Looking Into Abbott Laboratories's Recent Short Interest
Abbott Laboratories's (NYSE: ABT) short percent of float has risen 4.82% since its last report. The company recently reported that it has 14.97 million shares sold short , which is 0.87% of all regul...
Why We Chose Abbott Labs Stock Amid Tariff And DeepSeek Volatility
The last few weekends have been roiled by headlines. Here's why we took a different direction on this medical stock this week.
Delhivery appoints Vani Venkatesh as Chief Business Officer
Delhivery, India’s largest fully integrated logistics service provider, has appointed Vani Venkatesh as Chief Business Officer (CBO), effective February 28, 2025. With over 20 years of leadership expe...
Here are the best performing dividend aristocrats stocks in 2025
Dividend aristocrat stocks have largely done well in the past few years. The closely-followed ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has jumped by over 133% from its lowest level in 2020.
Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care
New survey shows 40% of people living with diabetes have skipped or missed a doctor's appointment due to shame or stigma1 70% of people with diabetes said supportive comments from others can significa...
Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories
Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories
Musk adds Shell, Nestlé, Lego to X advertiser 'boycott' lawsuit
Elon Musk’s X is adding several more companies to its lawsuit accusing firms of conspiring on an advertising "boycott" on the social media platform. The newest complaint, filed over the weekend, adds ...
Cancer Diagnostics Market Size is Expected to Reach USD 178.26 Billion by 2033, Growing at a CAGR of 5.91%: Straits Research
New York, United States, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Cancer diagnostics is the process of identifying biomarkers, proteins, and other indicators that assist in identifying a cancerous tumor. Pla...
X Adds Nestlé, Lego, Shell, and Others to Advertising ‘Boycott’ Lawsuit
X (formerly Twitter) has added seven more advertisers to its lawsuit alleging brands collectively "conspired" to "withhold billions in advertising revenue," from the platform following Elon Musk's $44...
Elon Musk's X Bolsters Antitrust Lawsuit With Additional Advertisers
Elon Musk ‘s X has expanded its antitrust lawsuit, incorporating more prominent advertisers into the list of defendants. The lawsuit charges these advertisers with a collective conspiracy to boycott a...
Elon Musk's X is suing more advertisers over ad 'boycott'
Nestlé, Abbott Laboratories, Colgate, Lego, Pinterest, Tyson Foods, and Shell have been added as new defendants in X's antitrust lawsuit.
My Best Dividend Aristocrats For February 2025
The ProShares S&P 500 Dividend Aristocrat ETF posted its 3rd worst monthly return in December, falling by 7.69%. I present 3 strategies that can theoretically beat the dividend aristocrat index in the...
The Art of Valuation: Discovering Abbott Laboratories's Intrinsic Value
The Art of Valuation: Discovering Abbott Laboratories's Intrinsic Value
This Is What Whales Are Betting On Abbott Laboratories
Financial giants have made a conspicuous bearish move on Abbott Laboratories. Our analysis of options history for Abbott Laboratories (NYSE: ABT) revealed 20 unusual trades. Delving into the details,...
Abbott To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page . Morgan St...
Is There More Upside For ABT Stock After A 10% Jump In A Week?
Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1.34 o...
Abbott Laboratories: Strong Q4 Results And Bullish Outlook
Lightning Round: I prefer SoFi to Nu Holdings, says Jim Cramer
'Mad Money' host Jim Cramer weighs in on stock including: Tetra Technologies, Abbott Labs, Nu Holdings, Wendy's, and Casella Waste Systems.
Market Whales and Their Recent Bets on ABT Options
Investors with a lot of money to spend have taken a bearish stance on Abbott Laboratories (NYSE: ABT). And retail traders should know. We noticed this today when the positions showed up on publicly a...
What Can The Dividend Kings Deliver In 2025?
The Dividend Kings underperformed the broad U.S. equity market in 2024, achieving a 5.53% total return compared to the S&P 500's 24.89%. 2024 returns for the Dividend Kings were primarily driven by ea...
Why Is Abbott Stock Trading Higher On Thursday?
On Wednesday, Abbott Laboratories ABT reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion.
Two Contrarian Dividends With Triple-Digit Potential For Trump 2.0
Tariff Day has left us with Canada and Mexico in the crosshairs. With North American trade in focus, this may actually give a respite to stocks with supply chains elsewhere and light a fire under them...